OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
28 hedge funds and large institutions have $13.2M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.55%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
7
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
$591K |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$4.81M |
| 3 |
BlackRock
New York
|
$385K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
$86K |
| 5 |
Northern Trust
Chicago,
Illinois
|
$671K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AF
26
Advisornet Financial
Minnetonka,
Minnesota
| $1K | – | – | – |
|
|
WAP
27
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| $1K | – | – | – |
|
28
Fidelity Investments
Boston,
Massachusetts
| $1K | +$1K | +75 | New |
|
29
Victory Capital Management
San Antonio,
Texas
| – | -$10K | -683 | Closed |
|
|
IA
30
IFP Advisors
Tampa,
Florida
| – | -$2K | -112 | Closed |
|